受强制性开放获取政策约束的文章 - sameer mirza了解详情
无法在其他位置公开访问的文章：2 篇
3D bioprinting of breast cancer models for drug resistance study
Y Wang, W Shi, M Kuss, S Mirza, D Qi, A Krasnoslobodtsev, J Zeng, ...
ACS biomaterials science & engineering 4 (12), 4401-4411, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
The characteristics and prognostic significance of histone H1 expression in breast cancer
AG Lashen, N Almalki, M Toss, S Mirza, MI Malki, CS Rutland, ...
Pathology, 2024
强制性开放获取政策： UK Research & Innovation
可在其他位置公开访问的文章：31 篇
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins
S Mirza, G Sharma, R Parshad, SD Gupta, P Pandya, R Ralhan
Journal of breast cancer 16 (1), 23-31, 2013
强制性开放获取政策： Canadian Institutes of Health Research
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
G Dagar, A Gupta, T Masoodi, S Nisar, M Merhi, S Hashem, R Chauhan, ...
Journal of translational medicine 21 (1), 449, 2023
强制性开放获取政策： Department of Biotechnology, India, Department of Science & Technology, India
Mouse models of estrogen receptor-positive breast cancer
S Mohibi, S Mirza, H Band, V Band
Journal of carcinogenesis 10, 2011
强制性开放获取政策： US National Institutes of Health
3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition
Y Wang, S Mirza, S Wu, J Zeng, W Shi, H Band, V Band, B Duan
Oncotarget 9 (63), 32191, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program
H Luan, B Mohapatra, TA Bielecki, I Mushtaq, S Mirza, TA Jennings, ...
Cancer research 78 (10), 2524-2535, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Susan G. Komen
Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression
S Mohibi, CB Gurumurthy, A Nag, J Wang, S Mirza, Y Mian, M Quinn, ...
Journal of Biological Chemistry 287 (35), 29442-29456, 2012
强制性开放获取政策： US National Institutes of Health
Pan-cancer analysis reveals the diverse landscape of novel sense and antisense fusion transcripts
NN Vellichirammal, A Albahrani, JK Banwait, NK Mishra, Y Li, ...
Molecular Therapy-Nucleic Acids 19, 1379-1398, 2020
强制性开放获取政策： US National Institutes of Health
Embedded bioprinting of breast tumor cells and organoids using low‐concentration collagen‐based bioinks
W Shi, S Mirza, M Kuss, B Liu, A Hartin, S Wan, Y Kong, B Mohapatra, ...
Advanced Healthcare Materials 12 (26), 2300905, 2023
强制性开放获取政策： US Department of Defense, US National Institutes of Health
A novel interaction of ecdysoneless (ECD) protein with R2TP complex component RUVBL1 is required for the functional role of ECD in cell cycle progression
RA Mir, A Bele, S Mirza, S Srivastava, AA Olou, SA Ammons, JH Kim, ...
Molecular and cellular biology, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability
S Mirza, BJ Katafiasz, R Kumar, J Wang, S Mohibi, S Jain, CB Gurumurthy, ...
Cell Cycle 11 (22), 4266-4274, 2012
强制性开放获取政策： US National Institutes of Health
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients
X Zhao, S Mirza, A Alshareeda, Y Zhang, CB Gurumurthy, A Bele, JH Kim, ...
Breast cancer research and treatment 134, 171-180, 2012
强制性开放获取政策： US National Institutes of Health
Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion
AI Aljohani, MS Toss, KA El-Sharawy, S Mirza, GR Ball, AR Green, ...
American journal of cancer research 12 (2), 469, 2022
强制性开放获取政策： UK Research & Innovation
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients
S Mirza, EA Rakha, A Alshareeda, S Mohibi, X Zhao, BJ Katafiasz, ...
Breast cancer research and treatment 137, 721-731, 2013
强制性开放获取政策： US National Institutes of Health
Epidermal growth factor receptor activation promotes ADA3 acetylation through the AKT-p300 pathway
S Srivastava, S Mohibi, S Mirza, H Band, V Band
Cell Cycle 16 (16), 1515-1525, 2017
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Susan G. Komen
Acetylation of mammalian ADA3 is required for its functional roles in histone acetylation and cell proliferation
S Mohibi, S Srivastava, A Bele, S Mirza, H Band, V Band
Molecular and cellular biology 36 (19), 2487-2502, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC
NI Griffin, G Sharma, X Zhao, S Mirza, S Srivastava, BJ Dave, ...
Breast Cancer Research 18, 1-15, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Alteration/deficiency in activation 3 (ADA3) protein, a cell cycle regulator, associates with the centromere through CENP-B and regulates chromosome segregation
S Mohibi, S Srivastava, J Wang-France, S Mirza, X Zhao, H Band, V Band
Journal of Biological Chemistry 290 (47), 28299-28310, 2015
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways
DA Jerjees, OH Negm, ML Alabdullah, S Mirza, M Alkaabi, MR Hameed, ...
Breast cancer research and treatment 150, 91-103, 2015
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定